The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2015
DOI: 10.1097/med.0000000000000171
|View full text |Cite
|
Sign up to set email alerts
|

A run on the biobank

Abstract: These findings, from T1D donors across the disease spectrum, emphasize the notion that pathogenic heterogeneity is a hallmark of the disorder.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
20
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 37 publications
(20 citation statements)
references
References 60 publications
0
20
0
Order By: Relevance
“…The recent access to human pancreata for research purposes and the subsequent histological studies have filled important gaps in our understanding of pancreatic pathology (10,3133). However, many fundamental questions remain to be answered.…”
Section: Discussionmentioning
confidence: 99%
“…The recent access to human pancreata for research purposes and the subsequent histological studies have filled important gaps in our understanding of pancreatic pathology (10,3133). However, many fundamental questions remain to be answered.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, this study was performed to identify predictors that increase the odds of obtaining high quality human pancreatic RNA in samples made available through the Network for Pancreatic Organ Donors with Diabetes (nPOD) program. 20,21 This initiative has been in operation for over 9 years and includes a biobank composed mainly of pancreatic tissue obtained from deceased whole-organ donors in the United States recovered under stringent standard operating procedures. 19 …”
Section: Introductionmentioning
confidence: 99%
“…These studies suggest that, whereas the classical model may be operative in most cases of T1DM, there are likely to be subtypes of T1DM with different pathogenesis or modifiers111. Hence, studies indicate that in certain individuals, the destruction of β-cells is patchy, suggesting a role for additional factors conferring resistance to this autoimmune-mediated destruction in certain β-cells10. This finding also correlates with other studies demonstrating the presence of circulating C-peptide, and by inference functioning β-cells, in individuals with long-standing disease12.…”
mentioning
confidence: 99%
“…More recent work focused on the study of the pancreatic islet, the site of the β-cell destruction, has offered new insights into the pathogenesis of T1DM. These studies have been made possible largely through the efforts of the National Institutes of Health Integrated Islet Distribution Program, Belgian Beta Cell Bank and the JDRF Network for Pancreatic Organ Donors with Diabetes (JDRF nPOD) programme10. These studies suggest that, whereas the classical model may be operative in most cases of T1DM, there are likely to be subtypes of T1DM with different pathogenesis or modifiers111.…”
mentioning
confidence: 99%